| Literature DB >> 26597916 |
Justyna Wojcieszek1, Katarzyna Witkoś1, Lena Ruzik1, Katarzyna Pawlak2.
Abstract
An analytical procedure was proposed to estimate bioaccessibility of copper and zinc in Spirulina Pacifica tablets with respect to that of copper and zinc in gluconate complexes. Spirulina is the common name for diet supplements produced primarily from two species of cyanobacteria, namely Arthrospira platensis and Arthrospira maxima. Spirulina tablets are an excellent source of proteins, vitamins and minerals. To obtain information about the bioavailability of these elements, an in vitro bioaccessibility test was performed by application of a two-step protocol which simulated the gastric (pepsin) and intestinal (pancreatin) digestion. The species obtained were investigated by size exclusion chromatography on a chromatograph coupled to a mass spectrometer with inductively coupled plasma (SEC-ICP-MS) and an on-capillary liquid chromatograph coupled to an electrospray mass spectrometer (μ-HPLC-ESI-MS). Both copper and zinc were found to be highly bioaccessible in Spirulina tablets (90-111%) and those containing gluconate complexes (103% for Cu and 62% for Zn). In Spirulina tablets, copper was found to form two types of complex: (1) polar ones with glycine and aspartic acid and (2) more hydrophobic ones containing amino acids with cyclic hydrocarbons (phenylalanine, histidine, proline and tyrosine). Zinc and copper were also proved to form complexes during the digestion process with products of pepsin digestion, but the stability of these complexes is lower than that of the complexes formed in Spirulina. The results proving the involvement of proteins in the enhancement of copper and zinc bioaccessibility will be useful for the design of new copper and zinc supplements.Entities:
Keywords: Bioaccessibility; Capillary liquid chromatography–electrospray mass spectrometry; Copper complexes; Inductively coupled plasma mass spectrometry; Pepsin peptide map; Spirulina
Mesh:
Substances:
Year: 2015 PMID: 26597916 PMCID: PMC4709381 DOI: 10.1007/s00216-015-9162-8
Source DB: PubMed Journal: Anal Bioanal Chem ISSN: 1618-2642 Impact factor: 4.142
Fig. 1Analytical procedure for soft and enzymatic extraction of zinc and copper analysis
Amounts of elements in the extracts of Spirulina tablets and Zn/Cu gluconate tablets
| Cu, μg g−1 (%) | Zn, μg g−1 (%) | |
|---|---|---|
| Spirulina Pacifica | ||
| 30 mM Tris–HCl pH 7.4 | 2.9 ± 0.1 (20) | 9.4 ± 0.4 (20) |
| 2 % of SDS in water | 3.5 ± 0.1 (24) | 8.1 ± 0.3 (17) |
| Gastric digestion | 8.2 ± 0.2 (56) | 44.8 ± 1.1 (95) |
| Gastric and gastrointestinal digestion | 13.2 ± 0.2 (90) | 52.5 ± 1.7 (111) |
| Total amount of metal | 14.5 ± 0.4 | 46.7 ± 0.7 |
| Gluconate complexes | ||
| Tris–HCl pH 7.4 | 1286 ± 35 (90) | 13,263 ± 114 (55) |
| Gastric digestion | 1376 ± 36 (96) | 14,531 ± 134 (60) |
| Gastric and gastrointestinal digestion | 1475 ± 45 (103) | 15,148 ± 171 (62) |
| Total amount of metal | 1579 ± 40 | 20343 ± 356 |
Results represent an average amount established for 3 samples; each measured 3 times; % of total amount of metal
Fig. 2SEC–ICP–MS chromatograms obtained for supernatants of extracts of Spirulina tablets obtained with solutions of a 30 mM Tris–HCl (pH 7.4), b 2 % SDS in demineralized water, c ultrafiltrate of supernatant obtained with the same solution as in b, d 30 mM Tris–HCl (pH 7.4) extract of tablets containing Zn (dotted lines) and Cu (solid lines) gluconate
Fig. 3SEC–ICP–MS chromatograms of gastric (solid line) and gastrointestinal digests (dotted line) of a, b Spirulina; c, d gluconate complexes with Zn and Cu and e, f inorganic form of copper and zinc (10 and 40 μg/g, respectively). Left column a, c, e chromatograms are presented for copper; right column b, d, f chromatograms are presented for zinc
Fig. 4μ-HPLC–ESI–MS/MS chromatograms of Spirulina tablets after gastrointestinal digestion registered in positive ion SCAN mode (a) and the signal intensities of zinc and copper established by ICP–MS in fractions collected every 3 min (b). Chromatograms (a) were extracted for selected product ions, see Table 2 for details
Copper species observed in μ-HPLC–ESI–MS/MS spectra of Spirulina tablets after simulation of gastric and gastrointestinal digestion
| No. |
| [M + H]+/[M − H]−, M | Pepsin/pancreatin | Product ions of [M + H]+ or [M − H]− |
|---|---|---|---|---|
| 1 | 3.5 | 185*/ND, 184 | +/− | (ESI+) 69 (Imd), 127 (Imd + C3H7OH) |
| 2 | 5.2 | 258*/ND, 257. 1 | +/− | (ESI+) 70 (C4H7N), 84 (C4H5NO), |
| 3 | 14.7 | 274*/ND, 273.1 | +/+ | (ESI+) 72 (Prl), 173* (Pro=Cu − 3H2), |
| 4 | 24.1 | 360*/358*, 359.1 | +/− | (ESI+) 86 (C4H7NO), |
| 5 | 25.2 | 332*/330*, 331.1 | +/− | (ESI+) 86 (C4H7NO), |
| 6 | 29.0 | 330*/328*, 329.1 | +/− | (ESI -) 130 (C6H9NO3), |
| 7 | 29.7 | 316*/ND, 315.1 | +/+ | (ESI+) 86 (C4H7NO), |
| 8 | 29.9 | 344*/342*, 343.2 | +/− | (ESI−) 130 (C6H9NO3), 185 (300* − H4CO3Cu), |
| 9 | 30.0 | 374*/372*, 373.1 | +/− | (ESI+) 243* (Tyr=Cu − H2O) |
*Signals corresponding to the second isotope of copper/zinc (2 units higher)
ND not detected, M experimental monoisotopic mass established with 50–300 ppm accuracy, derHis histidine derivative obtained by loss of oxygen, Imd imidazole, Prl pyrrolidine
Fig. 5Mass spectra obtained by means of μ-HPLC–ESI–MS/MS in negative ion mode and extracted at 29.9 min in the SCAN mode (a) for comparison of theoretical (bars) and experimental isotopic profile (lines). The product ion (PI) mass spectra were obtained for the two most intense signals at b m/z 342 and c m/z 344 following isotopic profile of copper. Signals with an asterisk correspond to molecules containing metal (see also Table 2)